TITLE

Association between Prostate Cancer and Urinary Calculi: A Population-Based Study

AUTHOR(S)
Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Herng-Ching
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Understanding the reasons underlying the emerging trend and the changing demographics of Asian prostate cancer (PC) has become an important field of study. This study set out to explore the possibility that urinary calculi (UC) and PC may share an association by conducting a case-control study on a population-based database in Taiwan. Methods: The cases of this study included 2,900 subjects ≥ 40 years-old who had received their first-time diagnosis of PC and 14,500 randomly selected controls without PC. Conditional logistic regressions were employed to explore the association between PC and having been previously diagnosed with UC. Results: We found that prior UC was found among 608 (21.0%) cases and 2,037 (14.1%) controls (p<0.001). Conditional logistic regression analysis revealed that compared to controls, the odds ratio (OR) of prior UC for cases was 1.63 (95% CI = 1.47–1.80). Furthermore, we found that cases were more likely to have been previously diagnosed with kidney calculus (OR = 1.71; 95% CI = 1.42–2.05), bladder calculus (OR = 2.06; 95% CI = 1.32–3.23), unspecified calculus (OR = 1.66; 95% CI = 1.37–2.00), and ≥2 locations of UC (OR = 1.73; 1.47–2.02) than controls. However, there was no significant relationship between PC and prior ureter calculus. We also found that of the patients with UC, there was no significant difference between PC and treatment method. Conclusions: This investigation detected an association between PC and prior UC. These results highlight a potential target population for PC screening.
ACCESSION #
87625629

 

Related Articles

  • Genitourinary tumours, non-prostate.  // Annals of Oncology;2016 Supplement, Vol. 27, pix86 

    No abstract available.

  • Genitourinary tumours, prostate.  // Annals of Oncology;2016 Supplement, Vol. 27, pix90 

    No abstract available.

  • Oral agent shows promise for hormone-refractory PCa. Newman, Laura // Urology Times;Mar2002, Vol. 30 Issue 3, p14 

    Reports the benefits of exisulind and docetaxel for hormone-refractory prostate cancer. Absence of organ systems toxicities; Suppression of cyclic guanylic acid phosphodiesterase expression; Pharmacological properties of the apoptotic antineoplastic drug.

  • Genitourinary tumors, prostate.  // Annals of Oncology;Sep2012 Supplement 9, Vol. 23 Issue suppl_9, pix294 

    No abstract available.

  • Gemcitabine may be effective in treating advanced PCa. Bowser, Andrew // Urology Times;May98, Vol. 26 Issue 5, p12 

    Presents information on a study regarding the effectivity of chemotherapy agent gemcitabine hydrochloride in treating advanced prostate cancer. Details on the study; Findings of the study; Additive cytotoxic effect of the agent.

  • Can CAPE be used as ideal antitumor agent "safely"? Erdis, E. // European Review for Medical & Pharmacological Sciences;Feb2013, Vol. 17 Issue 4, p567 

    A letter to the editor is presented in response to the article "The Anticancer Mechanism of Caffeic Acid Phenethyl Ester (CAPE): Review of Melanomas, Lung and Prostate Cancers," by G. Ozturk and colleagues in the 2012 issue.

  • Chemo agent shows novel action vs. refractory PCa. Newman, Laura // Urology Times;Apr2003, Vol. 31 Issue 4, p10 

    Reports on the effectiveness of an investigational drug called CP461 as a single agent in patients with hormone-refractory prostate cancer. Greater potency than exisulind; Chemotherapeutic effects of taxanes; Induction of cell death by the drug by different actions than the taxanes or other...

  • Abiraterone comes out on top in prostate cancer.  // PharmacoEconomics & Outcomes News;6/23/2012, Issue 656, p11 

    The article presents two cost-utility analyses, by U. Persson and L.S. Wilson and their respective colleagues comparing abiraterone and cabazitaxel in the treatment of metastatic castration-resistant prostate cancer, presented at the 17th Annual International Meeting of the International Society...

  • Antineoplastics.  // Reactions Weekly;1/11/2014, Issue 1483, p14 

    The article presents a case report on the adverse reaction of antineoplastics to an elderly man with prostate cancer who developed various toxicities during chemotherapy combined with the treatment.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics